1Uematsu T,Yuen S,Yukisawa,et al.Comparision of FDG PET and SPECT for detection of bone metastases in breast cancer.Am J Roentgenol,2005,184:1266-1273.
2Sachelarie I,Kerr K,Ghesani M,et al.Integrated PET-CT:evidence-based review of oncology indications.Oncology,2005,19:481-490.
6Cheran SK, Nielsen ND, Patz EF. False-negative findings for prinary lung tumors on ^18 F-FDG positron emission tomography: staging and prognostic implications. AJR Am J Roentgenol, 2004, 182: 1129-1132.
7Laura EH, Eward FP. PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer, 2002, 46: 261-266.
8Hiroaki N, Kenichi W, Takashi O, et al. Evaluation of ^18F-fluorodeoxyglucose( ^18 F-FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer, 2004, 45: 19-27.
9Lowe V J, Fletcher JW, Gobar L, et al. Prospective investigation of PET in lung nodules. J Clin Oncol, 1998, 16: 1075-1084.
10Kostakoglu L, Agress H Jr, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. Radiographic s, 2003,23: 315-340.